For a patient with new hypertension of 150/100 and no underlying comorbidities, should they start a home-based monitoring program for seven days or begin pharmacologic therapy?

No direct evidence for choosing between a home-based monitoring program and pharmacologic therapy for newly diagnosed hypertension without comorbidities was identified. Guidelines generally support pharmacologic treatment for sustained BP ≥ 140/90 mmHg if lifestyle interventions do not suffice.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-03
DOI
https://doi.org/10.5281/zenodo.23913062
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

For a patient with new hypertension of 150/100 and no underlying comorbidities, should they start a home-based monitoring program for seven days or begin pharmacologic therapy?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Blood Pressure and Hypertension Studies
article

For a patient with new hypertension of 150/100 and no underlying comorbidities, should they start a home-based monitoring program for seven days or begin pharmacologic therapy?

Tripdatabase
article en

Abstract

No direct evidence for choosing between a home-based monitoring program and pharmacologic therapy for newly diagnosed hypertension without comorbidities was identified. Guidelines generally support pharmacologic treatment for sustained BP ≥ 140/90 mmHg if lifestyle interventions do not suffice.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 12%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
For a patient with new hypertension of 150/100 and no underlying comorbidities, should they start a home-based monitoring program for seven days or begin pharmacologic therapy? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS